—so it's important not to have a false sense that when this agreement enters into force, those provisions will immediately enter force.
More broadly, what CETA does highlight is that we need a broader look at Canada's pharma strategy, and that is something that my colleague, the Minister of Health, is doing.
I think it's also worth pointing out and worth Canadians knowing that drug prices in European countries like Germany, France, the U.K., are actually lower than in Canada, so the issue is—